Overall survival and subsequent therapy patterns in Japanese patients with ER+/HER2- advanced breast cancer treated with palbociclib plus letrozole in the first-line setting: a final analysis. - Takahashi M; Yasojima H; Osako T; Inoue K; Kawashima M; Maeda H; Ito M; Sagara Y; Yonemori K; Hattori M; Yamamoto N; Muramatsu Y; et al. (Breast cancer (Tokyo, Japan), 2025)